Inflammatory monocytes, which highly express CCR2 and respond to CCL2 produced by tumor and stromal cells, are recruited to metastatic sites such as the lungs and liver before tumor cells and differentiate into MAMs, secreting VEGF and promoting tumor cell metastasis (211, 212). The gene discussed is CCL2; the disease is neoplasm.